H-1B Filings
25
DOL labor condition applications on file
Alexion Pharmaceuticals, Inc. in MA (Management of Companies) is a sponsorship-and-safety profile: 25 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
Alexion Pharmaceuticals, Inc. (MA): · 25 H-1B LCAs at a $170,100 disclosed median · OSHA Grade A (DART 0.09)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Alexion Pharmaceuticals, Inc. in MA carries 25 H-1B wage filings on record, a $170,100 median wage across 24 disclosed-wage positions (above the $120,000 national median), a strong A OSHA safety grade and no WARN layoff notices on file. H-1B filing volume ranks #1,072 of 36,919 sponsors in this corpus (about the 97th percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.
The record at a glance
According to U.S. Department of Labor, OSHA, and state WARN Act filings, Alexion Pharmaceuticals, Inc. carries 25 H-1B wage filings on record, a $170,100 median wage across 24 disclosed-wage positions (above the $120,000 national median), a strong A OSHA safety grade and no WARN layoff notices on file. In this corpus, H-1B filing volume ranks #1,072 of 36,919 sponsors in this corpus (about the 97th percentile), and disclosed median wage sits at the 82nd percentile of 178,031 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
DOL LCA release change
H-1B Filings
25
DOL labor condition applications on file
Median H-1B Salary
$170,100
Across 24 disclosed positions
OSHA Safety Grade
Grade A · DART 0.09
vs 0.33 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where Alexion Pharmaceuticals, Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$170,100 Top 18% higher than 82% of 178,031 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (-25.9% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | Alexion Pharmaceuticals, Inc. | DOL OFLC / OSHA |
| Industry | Management of Companies | NAICS / DOL |
| State | MA | U.S. Federal Records |
| H-1B Filings | 25 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $170,100 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.09 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
Alexion Pharmaceuticals, Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in MA (Management of Companies). In this corpus, H-1B filing volume ranks #1,072 of 36,919 sponsors in this corpus (about the 97th percentile); disclosed median wage sits at the 82nd percentile of 178,031 credible H-1B wage rows; OSHA DART rate is safer than roughly 99% of 135,691 employers with an establishment injury record.
| Job Title | Median |
|---|---|
| Director, Commercial Data Analytics and Reporting | $255,000 |
| Director, Commercial Data Analytics and Reporting | $255,000 |
| Director, CMC Team Lead | $228,776 |
| Director, CMC Team Lead | $228,776 |
| Director, Study Start-Up and Site Partnerships | $228,000 |
| Associate Director, Clinical Supply Lead | $195,000 |
| Associate Director, Clinical Supply Lead | $195,000 |
| Associate Director Development Asset Quality Meta | $194,324 |
| Associate Director, AI Diagnostics | $190,000 |
| Principal Engineer, Biologics Drug Substance Tech. Transfer | $176,000 |
| Regulatory Publishing Manager | $170,100 |
| Regulatory Publishing Manager | $170,100 |
| Principal Engineer, Biologics Drug Substance Tech. Transfer | $170,000 |
| Senior Manager, Data Analytics and Insights | $164,815 |
| Senior Manager, Quality Management System Analytics | $163,613 |
| Sr Scientist, Process Analytical Technologies & Chemometrics | $155,000 |
| Senior Engineer II, Injectable Drug Product Development | $145,000 |
| Scientist II | $141,008 |
| Development Scientist II, Analytical Dev & Clinical QC | $139,797 |
| Sr. Scientist I, Analytical Development and Clinical Supply | $135,000 |
| Development Scientist I, Analytical Dvlpmt and Clinical QC | $130,625 |
| Senior Engineer, Biologics Drug Substance Tech Transfer | $128,238 |
| Scientist I, Injectables Drug Product Development | $121,293 |
| Associate Scientist III, Upstream Process Development | $96,900 |
Alexion Pharmaceuticals, Inc. operating in MA within the Management of Companies sector: the company has filed 25 H-1B labor condition applications, of which 24 disclose a usable wage figure with a median of $170,100. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.
On workplace safety, Alexion Pharmaceuticals, Inc. posted a DART (Days Away, Restricted, Transferred) rate of 0.09 injuries per 100 full-time workers, compared with the hours-weighted average of 0.33 for the same 2-digit NAICS sector in OSHA ITA 2022–2023 filings. Our composite grade of "A" is that employer-to-sector ratio (A ≤0.5× sector · B ≤0.8× · C ≤1.2× · D ≤1.8× · else F), so a job seeker can compare a hospital chain to a warehouse or a bank to a food processor without chasing down OSHA formulas. Across all years on file, OSHA logged 3 reportable injuries at this employer.
For Alexion Pharmaceuticals, Inc., the usable public record is dominated by H-1B labor-condition applications (25 on this profile) in Management of Companies; those filings are sponsorship intent, not headcount, and cuts below the WARN threshold may never appear here.
Alexion Pharmaceuticals, Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Management of Companies).
Total reported injuries on file: 3.
Alexion Pharmaceuticals, Inc.'s nearest H-1B-filing peers in Management of Companies (home state MA). Each card links to that employer's federal-records profile.
What to check before working with Alexion Pharmaceuticals, Inc.
For Alexion Pharmaceuticals, Inc., read sponsorship pay (25 H-1B LCAs, median $170,100) next to the OSHA safety grade (A).
Alexion Pharmaceuticals, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.